HSF-1 not only triggers the release of chaperones, it also stabilizes cell cytoskeletons, a new study reports.
A new study reports researchers have created a new framework for protein aggregation under acute stress.
Researchers provide new evidence of how to target and reverse the effects caused by the most common genetic mutations for Parkinson's.
Dopamine cells derived from stem cells could reverse many features of Parkinson's disease for a number of years.
Researchers report finding greater rates of mitochondrial mutations in the offspring of older mothers, as well as the mothers themselves.
Researchers report people with PSP experience more severe and extensive cognitive impairments than those with Parkinson's disease.
A new finding into how the body sorts and transports proteins within cells could lead to new treatments for some neurodegenerative disorders, researchers report.
A drug which is being evaluated for the treatment of Gaucher disease has been shown to help slow the progression of Parkinson's disease in mice, a new study reports.
Researchers discover how unmutated versions of PINK1 and PARKIN collaborate to rid cells of damaged mitochondria.
A protein associated with Parkinson's disease regulates neurotransmission by self association, a new study reports.
Researchers report they have uncovered a new treatment for perinatal brain injuries.
Using optogenetics to stimulate mice brains five days after a stroke helped improve motor control and brain chemistry, researchers report.
A new study reports that depression is under-treated in Parkinson's patients.
Dopamine Replacement Therapy Associated with Increase in Impulse Control Disorders Among Early Parkinson’s Disease Patients
Anxiety and depression are more common in newly diagnosed Parkinson's patients than in the general population, a new study reports.
A new technique, which uses acoustic pressure to help molecules pass through the BBB, could help in treatment neurodegenerative diseases like Parkinson's and Alzheimer's.